184 related articles for article (PubMed ID: 10821050)
1. Light-mediated antifungal activity of Echinacea extracts.
Binns SE; Purgina B; Bergeron C; Smith ML; Ball L; Baum BR; Arnason JT
Planta Med; 2000 Apr; 66(3):241-4. PubMed ID: 10821050
[TBL] [Abstract][Full Text] [Related]
2. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
[TBL] [Abstract][Full Text] [Related]
3. Purification of alkylamides from Echinacea angustifolia (DC.) Hell. Roots by high-speed countercurrent chromatography.
Lopes-Lutz D; Mudge E; Ippolito R; Brown P; Schieber A
J Agric Food Chem; 2011 Jan; 59(2):491-4. PubMed ID: 21190380
[TBL] [Abstract][Full Text] [Related]
4. Absorption of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral application of Echinacea purpurea tincture.
Dietz B; Heilmann J; Bauer R
Planta Med; 2001 Dec; 67(9):863-4. PubMed ID: 11745026
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
6. Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats.
Ardjomand-Woelkart K; Kollroser M; Magnes C; Sinner F; Frye RF; Derendorf H; Bauer R; Butterweck V
Planta Med; 2011 Nov; 77(16):1794-9. PubMed ID: 21604240
[TBL] [Abstract][Full Text] [Related]
7. The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS.
Goey AK; Rosing H; Meijerman I; Sparidans RW; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():151-6. PubMed ID: 22770780
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract.
Guiotto P; Woelkart K; Grabnar I; Voinovich D; Perissutti B; Invernizzi S; Granzotto M; Bauer R
Phytomedicine; 2008 Aug; 15(8):547-54. PubMed ID: 18583121
[TBL] [Abstract][Full Text] [Related]
9. GC-MS analysis of the lipophilic principles of Echinacea purpurea and evaluation of cucumber mosaic cucumovirus infection.
Hudaib M; Fiori J; Bellardi MG; Rubies-Autonell C; Cavrini V
J Pharm Biomed Anal; 2002 Aug; 29(6):1053-60. PubMed ID: 12110390
[TBL] [Abstract][Full Text] [Related]
10. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
Gulledge TV; Collette NM; Mackey E; Johnstone SE; Moazami Y; Todd DA; Moeser AJ; Pierce JG; Cech NB; Laster SM
J Ethnopharmacol; 2018 Feb; 212():166-174. PubMed ID: 29042288
[TBL] [Abstract][Full Text] [Related]
11. Alkamides from Echinacea inhibit cyclooxygenase-2 activity in human neuroglioma cells.
Hinz B; Woelkart K; Bauer R
Biochem Biophys Res Commun; 2007 Aug; 360(2):441-6. PubMed ID: 17599805
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I).
Binns SE; Hudson J; Merali S; Arnason JT
Planta Med; 2002 Sep; 68(9):780-3. PubMed ID: 12357386
[TBL] [Abstract][Full Text] [Related]
14. Echinacea: anatomy, phytochemical pattern, and germination of the achene.
Schulthess BH; Giger E; Baumann TW
Planta Med; 1991 Aug; 57(4):384-8. PubMed ID: 1775583
[TBL] [Abstract][Full Text] [Related]
15. High performance liquid chromatography/electrospray ionization mass spectrometry for simultaneous analysis of alkamides and caffeic acid derivatives from Echinacea purpurea extracts.
Cech NB; Eleazer MS; Shoffner LT; Crosswhite MR; Davis AC; Mortenson AM
J Chromatogr A; 2006 Jan; 1103(2):219-28. PubMed ID: 16298376
[TBL] [Abstract][Full Text] [Related]
16. Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations.
Livesey J; Awang DV; Arnason JT; Letchamo W; Barrett M; Pennyroyal G
Phytomedicine; 1999 Nov; 6(5):347-9. PubMed ID: 11962542
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cannabinoid receptor activity of ketoalkenes from Echinacea pallida and nonnatural analogues.
Egger M; Pellett P; Nickl K; Geiger S; Graetz S; Seifert R; Heilmann J; König B
Chemistry; 2008; 14(35):10978-84. PubMed ID: 18979494
[TBL] [Abstract][Full Text] [Related]
18. [Lipid compounds from Echinacea purpurea].
Lii JR; Gao XF; Ai TM; Zhao YY
Zhongguo Zhong Yao Za Zhi; 2002 Jan; 27(1):40-2. PubMed ID: 12774354
[TBL] [Abstract][Full Text] [Related]
19. Chromatographic methods for metabolite profiling of virus- and phytoplasma-infected plants of Echinacea purpurea.
Pellati F; Epifano F; Contaldo N; Orlandini G; Cavicchi L; Genovese S; Bertelli D; Benvenuti S; Curini M; Bertaccini A; Bellardi MG
J Agric Food Chem; 2011 Oct; 59(19):10425-34. PubMed ID: 21830789
[TBL] [Abstract][Full Text] [Related]
20. Possible role of fat tissue in the pharmacokinetics of Dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral administration of Echinacea angustifolia extract in rats.
Jedlinszki N; Rédei D; Haller J; Freund TF; Hohmann J; Zupkó I
Nat Prod Commun; 2014 Jun; 9(6):843-5. PubMed ID: 25115096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]